[
    [
        {
            "time": "",
            "orginal_text": "龙头股突然躺倒？高瓴抛售躲过大跌，公募明星基金分歧显现",
            "features": {
                "keywords": [
                    "龙头股",
                    "高瓴",
                    "抛售",
                    "大跌",
                    "公募基金",
                    "分歧"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "股票"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "龙头股突然躺倒？高瓴抛售躲过大跌，公募明星基金分歧显现",
            "scores": {
                "News_content": "龙头股突然躺倒？高瓴抛售躲过大跌，公募明星基金分歧显现",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "年末盘点 | 2021募资之王：最能“忽悠”LP的投资人",
            "features": {
                "keywords": [
                    "募资",
                    "投资人",
                    "LP"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "投资"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "年末盘点 | 2021募资之王：最能“忽悠”LP的投资人",
            "scores": {
                "News_content": "年末盘点 | 2021募资之王：最能“忽悠”LP的投资人",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "北向资金追平年内最长净买入记录，山西汾酒净卖出额创历史新高",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买入",
                    "山西汾酒",
                    "净卖出"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "北向资金追平年内最长净买入记录，山西汾酒净卖出额创历史新高",
            "scores": {
                "News_content": "北向资金追平年内最长净买入记录，山西汾酒净卖出额创历史新高",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "恒指收涨0.23%，医药股强势反弹、煤炭股爆发",
            "features": {
                "keywords": [
                    "恒指",
                    "医药股",
                    "煤炭股",
                    "反弹",
                    "爆发"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "煤炭"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "恒指收涨0.23%，医药股强势反弹、煤炭股爆发",
            "scores": {
                "News_content": "恒指收涨0.23%，医药股强势反弹、煤炭股爆发",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "外资巨头增持A股核心资产，这些股被大幅增持！风格要变了？",
            "features": {
                "keywords": [
                    "外资",
                    "A股",
                    "核心资产",
                    "增持",
                    "风格变化"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "股票"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "外资巨头增持A股核心资产，这些股被大幅增持！风格要变了？",
            "scores": {
                "News_content": "外资巨头增持A股核心资产，这些股被大幅增持！风格要变了？",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "瑞银：维持泰格医药“买入”评级，目标价降29.6%至173.82港元",
            "features": {
                "keywords": [
                    "瑞银",
                    "泰格医药",
                    "买入",
                    "目标价下降"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "瑞银：维持泰格医药“买入”评级，目标价降29.6%至173.82港元",
            "scores": {
                "News_content": "瑞银：维持泰格医药“买入”评级，目标价降29.6%至173.82港元",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "瑞银：维持泰格医药(03347)“买入”评级 目标价降29.6%至173.82港元",
            "features": {
                "keywords": [
                    "瑞银",
                    "泰格医药",
                    "买入",
                    "目标价下降"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "瑞银：维持泰格医药(03347)“买入”评级 目标价降29.6%至173.82港元",
            "scores": {
                "News_content": "瑞银：维持泰格医药(03347)“买入”评级 目标价降29.6%至173.82港元",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "[异动股]泰格医药(03347.HK)涨4.36%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[异动股]泰格医药(03347.HK)涨4.36%",
            "scores": {
                "News_content": "[异动股]泰格医药(03347.HK)涨4.36%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "药明康德跌停 “要命”，“医药女神”葛兰旗下基金单日大跌4.24%",
            "features": {
                "keywords": [
                    "药明康德",
                    "跌停",
                    "葛兰",
                    "基金",
                    "大跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "药明康德跌停 “要命”，“医药女神”葛兰旗下基金单日大跌4.24%",
            "scores": {
                "News_content": "药明康德跌停 “要命”，“医药女神”葛兰旗下基金单日大跌4.24%",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "每日理财观察: 中国11月宏观经济数据出炉",
            "features": {
                "keywords": [
                    "宏观经济",
                    "数据出炉"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "经济"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "每日理财观察: 中国11月宏观经济数据出炉",
            "scores": {
                "News_content": "每日理财观察: 中国11月宏观经济数据出炉",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "22股获券商买入评级，康泰生物目标涨幅达97.29%",
            "features": {
                "keywords": [
                    "券商",
                    "买入评级",
                    "康泰生物",
                    "目标涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "22股获券商买入评级，康泰生物目标涨幅达97.29%",
            "scores": {
                "News_content": "22股获券商买入评级，康泰生物目标涨幅达97.29%",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]